These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5002300)

  • 21. Design of metallocenic drugs.
    Engel J; Schumacher W; Schönenberger H
    IARC Sci Publ; 1986; (78):295-307. PubMed ID: 3583395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid.
    Alati T; Worzalla JF; Shih C; Bewley JR; Lewis S; Moran RG; Grindey GB
    Cancer Res; 1996 May; 56(10):2331-5. PubMed ID: 8625328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS; Wood HB; Engle RR; Venditti JM; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):137-229. PubMed ID: 4350012
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies with 8-azainosine, a cytotoxic nucleoside with antitumor activity.
    Bennett LL; Vail MH; Allan PW; Laster WR
    Cancer Res; 1973 Mar; 33(3):465-71. PubMed ID: 4689896
    [No Abstract]   [Full Text] [Related]  

  • 25. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 26. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
    Loriga M; Fiore M; Sanna P; Paglietti G
    Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 28. Folate antagonists. 12. Antimalarial and antibacterial effects of 2,4-diamino-6-[(aralkyl and alicyclid)thio-, sulfinyl-, and sulfonyl]quinazolines.
    Elslager EF; Davoll J; Jacob P; Johnson AM; Johnson J; Werbel LM
    J Med Chem; 1978 Jul; 21(7):639-43. PubMed ID: 97382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.
    Leiter J; Abbott BJ; Schepartz SA
    Can Res Suppl; 1964 Dec; ():1093-353. PubMed ID: 5878218
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and evaluation of 6-arylactamido-2,4-diaminoquinazolines and related compounds as folic acid antagonists.
    Hynes JB; Ashton WT
    J Med Chem; 1975 Mar; 18(3):263-5. PubMed ID: 1094114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to chemotherapy.
    Hutchison DJ
    Ann N Y Acad Sci; 1971 Nov; 186():496-500. PubMed ID: 5002440
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV.
    Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I
    Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214
    [No Abstract]   [Full Text] [Related]  

  • 33. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pteridines. 2. New 6,7-disubstituted pteridines as potential antimalarial and antitumor agents.
    Rosowsky A; Chaykovsky M; Lin M; Modest EJ
    J Med Chem; 1973 Aug; 16(8):869-75. PubMed ID: 4200929
    [No Abstract]   [Full Text] [Related]  

  • 35. 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo.
    Bertino JR; Sawicki WL; Moroson BA; Cashmore AR; Elslager EF
    Biochem Pharmacol; 1979 Jun; 28(12):1983-7. PubMed ID: 454469
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of 5-substituted quinazolines as potential antimalarial agents.
    Ashton WT; Hynes JB
    J Med Chem; 1973 Nov; 16(11):1233-7. PubMed ID: 4583883
    [No Abstract]   [Full Text] [Related]  

  • 37. Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity.
    Elslager EF; Clarke J; Werbel LM; Worth DF; Davoll J
    J Med Chem; 1972 Aug; 15(8):827-36. PubMed ID: 4625530
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic aspects of homofolate derivatives in relation to amethopterin-resistant murine leukemia.
    Mead JA; Goldin A; Kisliuk RL; Friedkin M; Plante L; Crawford EJ; Kwok G
    Cancer Res; 1966 Nov; 26(11):2374-9. PubMed ID: 4959533
    [No Abstract]   [Full Text] [Related]  

  • 39. Active-site directed irreversible inhibitors of dihydrofolate reductase.
    Baker BR
    Ann N Y Acad Sci; 1971 Nov; 186():214-26. PubMed ID: 4943574
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and biological evaluation of analogues of 5,8-dideazaisofolic acid (IAHQ) modified at positions 2, 4 and 9.
    Hynes JB; Hagan RL; Shane B; Freisheim JH
    Adv Exp Med Biol; 1993; 338():417-20. PubMed ID: 8304148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.